White Paper: CMS Could Cover Obesity Drugs Using Medicare Flexibility

By Luke Zarzecki / September 27, 2023 at 4:49 PM
If CMS simply interpreted obesity as a chronic disease, it could cover anti-obesity drugs despite Congress’ longstanding ban on Medicare covering “agents when used for anorexia, weight loss or weight gain,” industry lawyers and patient advocates say in a new White Paper. The white paper comes as makers of popular obesity drugs and patient advocates also lobby Congress to mandate Medicare coverage. But the legislative effort may continue to be hung up by the potentially high cost of Medicare paying...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.